This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Macular Degeneration  • Articles for Residents  • Genetics  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Debra A. Schaumberg, ScD, OD, MPH; Susan E. Hankinson, ScD; Qun Guo, MSc; Eric Rimm, ScD; David J. Hunter, MBBS, ScD

Arch Ophthalmol. 2007;125(1):55-62.

Objectives  To delineate the magnitude of susceptibility to age-related macular degeneration (AMD) due to common variants in the gene for complement factor H (CFH) and the predicted gene LOC387715 and to determine whether these variants interact with modifiable risk factors.

Methods  We compared cases who developed AMD (n = 457) with 1071 age- and sex-matched control subjects in a prospective nested case-control study within the Nurses' Health Study and the Health Professionals Follow-up Study. We determined the incidence rate ratios and 95% confidence intervals (CIs) for AMD for each genotype and examined the interactions with modifiable risk factors.

Results  Participants with 1 or 2 copies of the Y402H variant of CFH were, respectively, 1.98 (95% CI, 1.64-2.40) and 3.92 (95% CI, 2.69-5.76) times more likely to develop AMD, whereas the incident rate ratios (95% CIs) for 1 and 2 copies of LOC387715 A69S were 2.38 (1.92-2.96) and 5.66 (3.69-8.76), respectively. The fraction of AMD cases attributable to these 2 variants was 63% (95% CI, 58%-68%). Subjects homozygous for both risk alleles had a 50-fold increased risk of AMD (95% CI, 10.8-237), and cigarette smoking and obesity multiplied the risks associated with these variants.

Conclusion  Age-related macular degeneration has emerged as a paradigmatic example of a common disease caused by the interplay of genetic predisposition and exposure to modifiable risk factors.

Author Affiliations: Division of Preventive Medicine (Dr Schaumberg) and Channing Laboratory (Drs Hankinson, Rimm, and Hunter and Ms Guo), Department of Medicine, Brigham and Women's Hospital, and Department of Ophthalmology (Dr Schaumberg), Harvard Medical School, and Program in Molecular and Genetic Epidemiology (Ms Guo and Dr Hunter) and Departments of Epidemiology (Drs Hankinson, Rimm, and Hunter) and Nutrition (Drs Rimm and Hunter), Harvard School of Public Health, Boston, Mass.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prediction Model for Prevalence and Incidence of Advanced Age-Related Macular Degeneration Based on Genetic, Demographic, and Environmental Variables
Seddon et al.
IOVS 2009;50:2044-2053.
ABSTRACT | FULL TEXT  

Complement Activation by Bisretinoid Constituents of RPE Lipofuscin
Zhou et al.
IOVS 2009;50:1392-1399.
ABSTRACT | FULL TEXT  

Combined Effects of Complement Factor H Genotypes, Fish Consumption, and Inflammatory Markers on Long-Term Risk for Age-related Macular Degeneration in a Cohort
Wang et al.
Am J Epidemiol 2009;169:633-641.
ABSTRACT | FULL TEXT  

Genotype-Phenotype Correlations for Exudative Age-Related Macular Degeneration Associated with Homozygous HTRA1 and CFH Genotypes
Leveziel et al.
IOVS 2008;49:3090-3094.
ABSTRACT | FULL TEXT  

Variants in the 10q26 Gene Cluster (LOC387715 and HTRA1) Exhibit Enhanced Risk of Age-Related Macular Degeneration along with CFH in Indian Patients
Kaur et al.
IOVS 2008;49:1771-1776.
ABSTRACT | FULL TEXT  

Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism
Droz et al.
Br J Ophthalmol 2008;92:513-517.
ABSTRACT | FULL TEXT  

Bringing the genetics of macular degeneration into focus
Haines et al.
Proc. Natl. Acad. Sci. USA 2007;104:16725-16726.
FULL TEXT  

Personalized Medicine in the Era of Genomics
Burke and Psaty
JAMA 2007;298:1682-1684.
FULL TEXT  

Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration
Spencer et al.
Hum Mol Genet 2007;16:1986-1992.
ABSTRACT | FULL TEXT  

Association of CFH Y402H and LOC387715 A69S With Progression of Age-Related Macular Degeneration
Seddon et al.
JAMA 2007;297:1793-1800.
ABSTRACT | FULL TEXT  

High-Sensitivity C-Reactive Protein, Other Markers of Inflammation, and the Incidence of Macular Degeneration in Women
Schaumberg et al.
Arch Ophthalmol 2007;125:300-305.
ABSTRACT | FULL TEXT  

Genetic Ophthalmology and the Era of Clinical Care
Sieving and Collins
JAMA 2007;297:733-736.
FULL TEXT  

Rapid Dissection of the Genetic Risk of Age-Related Macular Degeneration: Achieving the Promise of the Genomic Era
Haines and Pericak-Vance
JAMA 2007;297:401-402.
FULL TEXT  

Ophthalmic Genetics: At the Dawn of Discovery
Hyman et al.
Arch Ophthalmol 2007;125:9-10.
FULL TEXT